Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
Kawasaki R, Hirano H, Yamana K, Isozaki H, Kawamura S, Sanada Y, Bando K, Tabata A, Yoshikawa K, Azuma H, Takata T, Tanaka H, Sakurai Y, Suzuki M, Tarutani N, Katagiri K, Sawada SI, Sasaki Y, Akiyoshi K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: hirano h. Nanomedicine. 2023 Apr;49:102659. doi: 10.1016/j.nano.2023.102659. Epub 2023 Feb 21. Nanomedicine. 2023. PMID: 36822335
Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
Kawasaki R, Hirano H, Yamana K, Oshige A, Nishimura K, Kono N, Sanada Y, Bando K, Tabata A, Yasukawa N, Azuma H, Takata T, Sakurai Y, Tanaka H, Suzuki M, Tarutani N, Katagiri K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: hirano h. Chembiochem. 2023 Aug 1;24(15):e202300186. doi: 10.1002/cbic.202300186. Epub 2023 Jul 4. Chembiochem. 2023. PMID: 37069129
HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.
Yamana K, Kawasaki R, Kondo K, Hirano H, Kawamura S, Sanada Y, Bando K, Tabata A, Azuma H, Takata T, Sakurai Y, Tanaka H, Kodama T, Kawamoto S, Nagasaki T, Ikeda A. Yamana K, et al. Among authors: hirano h. Nanoscale Adv. 2023 Jun 1;5(15):3857-3861. doi: 10.1039/d3na00028a. eCollection 2023 Jul 25. Nanoscale Adv. 2023. PMID: 37496630 Free PMC article.
HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
Kawasaki R, Oshige A, Yamana K, Hirano H, Nishimura K, Miura Y, Yorioka R, Sanada Y, Bando K, Tabata A, Yasuhara K, Miyazaki Y, Shinoda W, Nishimura T, Azuma H, Takata T, Sakurai Y, Tanaka H, Suzuki M, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: hirano h. Chemistry. 2023 Dec 22;29(72):e202302486. doi: 10.1002/chem.202302486. Epub 2023 Nov 6. Chemistry. 2023. PMID: 37792507
Corrigendum: Sex-specific factors associated with acceptance of smartwatches among urban older adults: the Itabashi longitudinal study on aging.
Deguchi N, Osuka Y, Kojima N, Motokawa K, Iwasaki M, Inagaki H, Miyamae F, Okamura T, Hirano H, Awata S, Sasai H. Deguchi N, et al. Among authors: hirano h. Front Public Health. 2024 May 15;12:1416463. doi: 10.3389/fpubh.2024.1416463. eCollection 2024. Front Public Health. 2024. PMID: 38813408 Free PMC article.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ, Oh DY, Kato K, Arkenau T, Tabernero J, Correa MC, Zimina AV, Bai Y, Shi J, Lee KW, Wang J, Poddubskaya E, Pan H, Rha SY, Zhang R, Hirano H, Spigel D, Yamaguchi K, Chao Y, Wyrwicz L, Disel U, Cid RP, Fornaro L, Evesque L, Wang H, Xu Y, Li J, Sheng T, Yang S, Li L, Moehler M, Xu RH; RATIONALE-305 Investigators. Qiu MZ, et al. Among authors: hirano h. BMJ. 2024 May 28;385:e078876. doi: 10.1136/bmj-2023-078876. BMJ. 2024. PMID: 38806195 Clinical Trial.
1,583 results